FCA publishes guidance on its approach to cannabis-related companies looking to list in the UK
On 18 September the published guidance on the listing of cannabis-based businesses onto public stock exchanges in the UK. We consider the...
Cortex - Life Sciences Insights
Contributors
-
Solicitor -
-
Of Counsel -
Partner -
-
-
-
-
Senior Associate (Rechtsanwalt) -
Corporate Associate -
Senior Associate -
-
Associate - Intellectual Property and Technology -
-
Special Counsel -
Marketing & Business Development Manager
-
Trainee Solicitor
-
Partner -
-
Associate -
-
-
Senior Associate -
-
-
Solicitor -
Marketing Coordinator, International Practice Groups & Sectors
-
Associate -
Partner -
-
Partner -
Associate -
Global Co-Chair Life Science Partner -
Senior Associate -
Senior Marketing Manager -
-
-
Senior Associate -
-
Partner -
Lawyer -
-
-
Senior Associate -
Partner, Healthcare Industry Sector -
Partner -
Partner -
-
Partner -
Associate
-
-
Associate -
-
-
-
Associate
-
Senior Associate -
Senior Associate -
Partner, Head of Patents
DLA Piper Life Sciences Archive
- March 2021 (1)
- February 2021 (19)
- January 2021 (2)
- December 2020 (4)
- November 2020 (6)
- October 2020 (5)
- September 2020 (4)
- July 2020 (2)
- June 2020 (1)
- May 2020 (2)
- April 2020 (6)
- March 2020 (1)
- February 2020 (2)
- January 2020 (4)
- November 2019 (2)
- October 2019 (1)
- August 2019 (1)
- July 2019 (5)
- May 2019 (6)
- March 2019 (2)
- February 2019 (4)
- January 2019 (1)
- December 2018 (2)
- November 2018 (2)
- October 2018 (1)
- August 2018 (1)
- July 2018 (2)
- May 2018 (1)
- April 2018 (3)
- March 2018 (8)
- February 2018 (1)
- December 2017 (5)
- November 2017 (15)
- October 2017 (7)
Digital Therapeutics - evolution and entry into mainstream healthcare
Research undertaken by DLA Piper's Life Sciences sector in conjunction with The Lawyer seeks to understand the current developments in...
Changes to Australian medical device laws delayed
As the medical and healthcare sectors remain firmly focused on tackling the many and ongoing challenges of COVID-19, the Australian...
The wait is not over for approved medicinal CBD in Australia
We previously reported in our article “Developments in Australian CBD market” that the Pharmaceutical Benefits Advisory Committee (PBAC)...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net